n/a
Article Publish Status: FREE
Abstract Title:

Radioprotective Effect of Thymol Against Salivary Glands Dysfunction Induced by Ionizing Radiation in Rats.

Abstract Source:

Iran J Pharm Res. 2016 ;15(4):861-866. PMID: 28243283

Abstract Author(s):

Seyed Mohammad Abedi, Fateme Yarmand, Mina Motallebnejad, Maryam Seyedmajidi, Dariush Moslemi, Ali Bijani, Seyed Jalal Hosseinimehr

Article Affiliation:

Seyed Mohammad Abedi

Abstract:

The aim of this study was to investigate the radioprotective effect of thymol as a natural product against salivary glands dysfunction induced by ionizing radiation in rats. The rats were treated with thymol at dose of 50 mg/Kg before exposure to ionizing radiation at dose 15 Gy. Salivary gland function was evaluated with radioisotope scintigraphy and then salivary gland to background counts ratio was calculated. Ionizing radiation caused significant salivary glands dysfunction at the 3(th) and the 70(th) days with reduction in radioactivity uptake in salivary glands. Ratios of salivary gland to background radioactivities were 2.0± 0.05, 1.58 ± 0.62 and 1.99 ± 0.07 at 3(th) days for control, radiation, and thymol plus radiation groups, respectively. Thymol significantly protected acute and chronic salivary gland dysfunction induced by ionizing radiation in the rats.This finding may have been a promising application of thymol for the protection of salivary glands dysfunction induced by ionizing irradiation in patients exposed to radiation in head and neck cancer therapy.

Study Type : Animal Study

Print Options


Key Research Topics

This website is for information purposes only. By providing the information contained herein we are not diagnosing, treating, curing, mitigating, or preventing any type of disease or medical condition. Before beginning any type of natural, integrative or conventional treatment regimen, it is advisable to seek the advice of a licensed healthcare professional.

© Copyright 2008-2024 GreenMedInfo.com, Journal Articles copyright of original owners, MeSH copyright NLM.